New stem cell treatment offers hope for ALS patients

NCT ID NCT06169176

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 20 times

Summary

This trial provides early access to an experimental stem cell therapy called RAPA-501 for people with amyotrophic lateral sclerosis (ALS). The treatment uses a patient's own immune cells to potentially slow disease progression. It is available to adults 18 and older with a confirmed ALS diagnosis and reduced lung function. The goal is to control the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Barrow Neurological Institute

    Phoenix, Arizona, 85013, United States

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, 07601, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic Hospital Phoenix

    Scottsdale, Arizona, 85259, United States

  • Providence Portland Medical Center

    Portland, Oregon, 97213, United States

  • University of California Irvine Health

    Irvine, California, 92868, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

  • University of Iowa Health Care

    Iowa City, Iowa, 52242, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

Conditions

Explore the condition pages connected to this study.